Thermo Fisher Scientific lists the Ion PGM Dx system with the FDA as a class II medical device

Sept. 22, 2014

Thermo Fisher Scientific has completed the listing of its Ion PGM Dx next generation sequencing (NGS) system with the U.S. Food and Drug Administration (FDA) for clinical use as a class II medical device.

“Next generation sequencing is rapidly becoming an indispensable tool for clinical laboratories, allowing clinical professionals to simultaneously screen hundreds of genes from patient samples to provide key genetic information and enable patient enrollment within clinical trials,” says Mark Stevenson, President of Life Science Solutions at Thermo Fisher Scientific. “The Ion Torrent platform and accompanying reagents provide a number of advantages to clinical customers, enabling accurate and reliable genetic variant analysis from more samples due to low DNA input requirements (10ng) and faster turnaround times that reduce the time of sample to result.”

The new Ion PGM Dx System is intended for targeted sequencing of human genomic DNA using peripheral whole blood samples. It supports development and implementation of user-defined NGS diagnostic assays in a clinical laboratory and enables 21 CFR Part 11 compliance. The System was validated using a large control panel that contains an extensive number of germline variants that are representative of a range of human conditions. When using the System for diagnostic assay development, customers may define, validate, lock, and publish protocols in a role-based workflow for implementation into routine use, from library construction to variant calling.

The Ion PGM Dx System will include the instrument specific library kit, template kit, sequencing kit, and 318 chip, all manufactured under GMP. Based on 200bp chemistry, the library kit will also include barcodes to enable cost-effective and flexible processing of up to 16 samples within a single run. The System provides integrated data analysis software for sample and reagent tracking capability, QC metrics, audit trails, and a suite of software controls to aid clinical laboratories in maintaining high performance standards with the implementation of each new assay. Learn more about the Ion PGM Dx System.

Read more